04 October 2023
The recent 13th International Conference on the Molecular Biology and Pathogenesis of Clostridia (CLOSTPATH), in Banff, Canada this Sep 19th-23rd 2023, a prestigious and highly anticipated event, brought together top internationally recognized leaders, scientists and clinicians to explore and advance the field of clostridial molecular biology and pathogenesis, unravel the mysteries of clostridial bacteria, their mechanisms, and their impact on health and various industries, shaping the future of clostridial research.
Dr. Wiep Klaas Smits, an Associate Professor specializing in Medical Microbiology at the Leiden University Medical Center (LUMC), showcased his team’s ground-breaking work. Dr. Smits presented a poster titled “Towards controlled human Clostridioides difficile colonization and infection”, which also represents the collective efforts of both LUMC and the Inno4Vac CHIMICHURRI Subtopic 2 Partners’ support and research initiative for the development of a controlled human infection model (CHIM) for Clostridioides difficile.
Discover more on the CHIMICHURRI Subtopic 2 goals here: www.inno4vac.eu/st2chimichurri
Dr. Irina Meln (Project and Innovation Manager at the European Vaccine Initiative)
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101007799 (Inno4Vac). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA (www.imi.europa.eu). This communication reflects the author´s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.